tiprankstipranks
Advertisement
Advertisement

ONCY Stock Latest News

Oncolytics price target lowered to $5 from $10 at H.C. Wainwright
The FlyOncolytics price target lowered to $5 from $10 at H.C. Wainwright
19d ago
ONCY
Oncolytics Biotech gains FDA alignment on REO 033 trial
PremiumCompany Announcements
Oncolytics Biotech gains FDA alignment on REO 033 trial
20d ago
8K
ONCY
Oncolytics aligns with FDA on path for REO 033 expansion study
PremiumThe Fly
Oncolytics aligns with FDA on path for REO 033 expansion study
20d ago
ONCY
ONCY Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ONCY Upcoming Earnings Report: What to Expect?
1M ago
ONCY
Oncolytics Biotech Faces Nasdaq Minimum Bid Price Noncompliance
PremiumCompany Announcements
Oncolytics Biotech Faces Nasdaq Minimum Bid Price Noncompliance
1M ago
8K
ONCY
Oncolytics Biotech gains FDA Fast Track for pelareorep
PremiumCompany AnnouncementsOncolytics Biotech gains FDA Fast Track for pelareorep
2M ago
8K
ONCY
Oncolytics announces FDA Fast Track designation for pelareorep
Premium
The Fly
Oncolytics announces FDA Fast Track designation for pelareorep
2M ago
ONCY
Oncolytics Biotech advances REO 033 colorectal cancer program
Premium
Company Announcements
Oncolytics Biotech advances REO 033 colorectal cancer program
2M ago
8K
ONCY
Oncolytics provides clinical, regulatory update on REO 033
PremiumThe Fly
Oncolytics provides clinical, regulatory update on REO 033
2M ago
ONCY
Oncolytics Biotech Secures New Pelareorep Manufacturing Patent
PremiumCompany Announcements
Oncolytics Biotech Secures New Pelareorep Manufacturing Patent
3M ago
8K
ONCY
Oncolytics secures new patent for pelareorep manufacturing
PremiumThe Fly
Oncolytics secures new patent for pelareorep manufacturing
3M ago
ONCY
Oncolytics promotes John McAdory to COO
PremiumThe Fly
Oncolytics promotes John McAdory to COO
3M ago
CGON
ONCY
Oncolytics Biotech Strengthens Leadership with New COO, Director
PremiumCompany AnnouncementsOncolytics Biotech Strengthens Leadership with New COO, Director
3M ago
8K
ONCY
Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results
Premium
Company Announcements
Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results
3M ago
8K
ONCY
Oncolytics announces initial data from pelareorep combination study
Premium
The Fly
Oncolytics announces initial data from pelareorep combination study
3M ago
ONCY
Oncolytics Biotech to present data at ASCO 2026 on pelareorep
PremiumThe Fly
Oncolytics Biotech to present data at ASCO 2026 on pelareorep
4M ago
ONCY
Oncolytics Highlights Pelareorep Immune Activation Data at ASCO
PremiumCompany Announcements
Oncolytics Highlights Pelareorep Immune Activation Data at ASCO
4M ago
8K
ONCY
Jason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
PremiumRatings
Jason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
4M ago
ONCY
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
PremiumCompany Announcements
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
4M ago
8K
ONCY
Oncolytics says in alignment with FDA following pelareorep Type C meeting
PremiumThe FlyOncolytics says in alignment with FDA following pelareorep Type C meeting
4M ago
ONCY
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
Premium
Company Announcements
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
4M ago
8K
ONCY
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
Premium
Ratings
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
5M ago
ONCY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >